[go: up one dir, main page]

SMT202000705T1 - Combinazione di adapalene e benzoilperossido per il trattamento di acne grave - Google Patents

Combinazione di adapalene e benzoilperossido per il trattamento di acne grave

Info

Publication number
SMT202000705T1
SMT202000705T1 SM20200705T SMT202000705T SMT202000705T1 SM T202000705 T1 SMT202000705 T1 SM T202000705T1 SM 20200705 T SM20200705 T SM 20200705T SM T202000705 T SMT202000705 T SM T202000705T SM T202000705 T1 SMT202000705 T1 SM T202000705T1
Authority
SM
San Marino
Prior art keywords
adapalene
treatment
combination
benzoyl peroxide
severe acne
Prior art date
Application number
SM20200705T
Other languages
English (en)
Inventor
Matthew James Leoni
Michael Graeber
Vasant Manna
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53540775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT202000705(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of SMT202000705T1 publication Critical patent/SMT202000705T1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/327Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SM20200705T 2014-07-25 2015-07-16 Combinazione di adapalene e benzoilperossido per il trattamento di acne grave SMT202000705T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462029043P 2014-07-25 2014-07-25
EP15736304.5A EP3171857B1 (en) 2014-07-25 2015-07-16 Combination of adapalene and benzoyl peroxide for the treatment of severe acne
PCT/EP2015/066331 WO2016012352A1 (en) 2014-07-25 2015-07-16 Combination of adapalene and benzoyl peroxide for the treatment of severe acne

Publications (1)

Publication Number Publication Date
SMT202000705T1 true SMT202000705T1 (it) 2021-01-05

Family

ID=53540775

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20200705T SMT202000705T1 (it) 2014-07-25 2015-07-16 Combinazione di adapalene e benzoilperossido per il trattamento di acne grave

Country Status (24)

Country Link
US (2) US20170216231A1 (it)
EP (1) EP3171857B1 (it)
KR (1) KR20170035916A (it)
CN (1) CN107072939A (it)
AU (1) AU2015294100A1 (it)
BR (1) BR112017001434A2 (it)
CL (1) CL2017000088A1 (it)
CY (1) CY1124107T1 (it)
DK (1) DK3171857T3 (it)
ES (1) ES2828699T3 (it)
HR (1) HRP20201787T1 (it)
HU (1) HUE051351T2 (it)
IL (1) IL250199A0 (it)
LT (1) LT3171857T (it)
MA (1) MA40179B1 (it)
MX (1) MX2017000717A (it)
PT (1) PT3171857T (it)
RS (1) RS61017B1 (it)
RU (1) RU2017105074A (it)
SG (1) SG11201700449RA (it)
SI (1) SI3171857T1 (it)
SM (1) SMT202000705T1 (it)
TW (1) TW201609082A (it)
WO (1) WO2016012352A1 (it)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833841B1 (fr) 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
WO2003075908A1 (en) 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders
FR2903603B1 (fr) 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
FR2909000B1 (fr) * 2006-11-28 2009-02-06 Galderma Res & Dev S N C Snc Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations.
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
EP2282731A1 (en) * 2008-04-24 2011-02-16 Galderma Research & Development Combination therapy for acne vulgaris comprising adapalene 0.3% gel with clindamycin/benzoyl peroxide gel
CN103547256A (zh) * 2011-03-23 2014-01-29 加利福尼亚大学校务委员会 炎性和传染性皮肤病的治疗
EP3082785A1 (en) * 2013-12-19 2016-10-26 Galderma Research & Development Therapy regimen for treating severe acne related diseases

Also Published As

Publication number Publication date
RS61017B1 (sr) 2020-12-31
ES2828699T3 (es) 2021-05-27
RU2017105074A (ru) 2018-08-27
AU2015294100A1 (en) 2017-01-12
HRP20201787T1 (hr) 2021-04-16
TW201609082A (zh) 2016-03-16
MA40179B1 (fr) 2020-10-28
HUE051351T2 (hu) 2021-03-01
EP3171857A1 (en) 2017-05-31
EP3171857B1 (en) 2020-08-19
US20170216231A1 (en) 2017-08-03
KR20170035916A (ko) 2017-03-31
CN107072939A (zh) 2017-08-18
BR112017001434A2 (pt) 2017-12-05
WO2016012352A1 (en) 2016-01-28
IL250199A0 (en) 2017-03-30
US20170095434A1 (en) 2017-04-06
RU2017105074A3 (it) 2019-01-15
LT3171857T (lt) 2021-01-11
MA40179A (fr) 2017-05-31
MX2017000717A (es) 2017-05-01
CY1124107T1 (el) 2022-03-24
SG11201700449RA (en) 2017-02-27
CL2017000088A1 (es) 2017-09-01
PT3171857T (pt) 2020-11-19
DK3171857T3 (da) 2020-09-21
SI3171857T1 (sl) 2021-01-29

Similar Documents

Publication Publication Date Title
ZA201605946B (en) Treatments for resistant acne
IL273932A (en) Methods of treatment and prevention of viral infection
SI3524255T1 (sl) Sestavek za zdravljenje aken
IL252747A0 (en) A synergistic viscosity-reducing preparation of peroxide and hydroxylamine ester to increase viscosity-reducing efficiency
IL250692A0 (en) Medical treatments based on anamorelin
GB201411407D0 (en) Particle beam treatment
GB201412011D0 (en) Treatments
GB201423268D0 (en) The combination for acne cleansing and skin metabolism improving
EP3245125A4 (en) Pulsed locomotor
SG11201608222WA (en) Combination of adapalene and benzoyl peroxide for treating acne scars
PT3340975T (pt) Formulação para o tratamento de acne
SG11201700449RA (en) Combination of adapalene and benzoyl peroxide for the treatment of severe acne
AU2014902732A0 (en) Treatment and prophylaxis
PT3524255T (pt) Composição para o tratamento do acne
GB201403134D0 (en) Computational attention and the human mind for robotics
PL3206701T3 (pl) Canephron do leczenia zapalenia gruczołu krokowego
AU2014904752A0 (en) Methods for the treatment and prevention of iron overload
GB201412293D0 (en) Therapeutic treatments
GB201412285D0 (en) Therapeutic treatments
GB201406790D0 (en) Laser treatment
GB201415876D0 (en) Methods for the treatment and prevention of Ebola
EP3197686A4 (en) Re-feed prevention
AU2014901024A0 (en) Trolley treatment
AU2014900072A0 (en) Trolley treatment